Dr. med. et phil. nat. David Semela
chief of service
Gastroenterology/Hepatology · Dept. I
DIagnosis of typical nodular hyperplasia in the liver - use of a novel ultrasonic vascular Doppler technique
Sawatzki M, Semela D, Neuweiler J, Brand S (2018). DIagnosis of typical nodular hyperplasia in the liver - use of a novel ultrasonic vascular Doppler technique.
Oct 22, 2018DIagnosis of typical nodular hyperplasia in the liver - use of a novel ultrasonic vascular Doppler technique
Oct 22, 2018UEGW
Sawatzki Mikael, Semela David, Neuweiler Jörg, Brand Stephan
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
Geier A, Mullhaupt B, Bischoff-Ferrari H, Saleh L, Marques Maggio E, Jahn D, Bantel H, Tschopp O, Seifert B, Tay F, Semela D, Stirnimann G, Eichinger M, Dufour J. Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study. Scand J Gastroenterol 2018:1-7.
Sep 29, 2018Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
Sep 29, 2018Scand J Gastroenterol 2018:1-7
Geier Andreas, Mullhaupt Beat, Bischoff-Ferrari Heike A, Saleh Lanja, Marques Maggio Ewerton, Jahn Daniel, Bantel Heike, Tschopp Oliver, Seifert Burkhardt, Tay Fabian, Semela David, Stirnimann Guido, Eichinger Mareile, Dufour Jean-François
Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept
Popp F, Semela D, von Kempis J, Mueller R. Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept. BMJ Case Rep 2018; 2018
May 12, 2018Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept
May 12, 2018BMJ Case Rep 2018; 2018
Popp Florian, Semela David, von Kempis Johannes, Mueller Ruediger B
Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
Goossens N, Semmo N, Mullhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group. Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review. J Viral Hepat 2018; 25:920-929.
Apr 17, 2018Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
Apr 17, 2018J Viral Hepat 2018; 25:920-929
Goossens N, Semmo N, Mullhaupt B, Semela David, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L E, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Bachofner J, Mertens J, Terziroli Beretta-Piccoli B, Mullhaupt B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Kröger A, Bergamin I, Valli P, The Swiss Hepatitis C Cohort Study. Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland. Swiss Med Wkly 2018; 148:w14560.
Jan 18, 2018Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Jan 18, 2018Swiss Med Wkly 2018; 148:w14560
Bachofner Jacqueline, Mertens Joachim, Terziroli Beretta-Piccoli Benedetta, Mullhaupt Beat, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique L, Baserga Adriana, Künzler-Heule Patrizia, Kröger Arne, Bergamin Irina, Valli Piero V, The Swiss Hepatitis C Cohort Study
Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland
Terziroli Beretta-Piccoli B, Carbone M, Invernizzi P, Baserga A, Oneta C, Filipowicz Sinnreich M, Giostra E, Bihl F, Kalid-de Bakker C, Stickel F, Helbling B, Hessler R, Semela D, Cerny A, Stirnimann G, Mertens J. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland. Clin Rev Allergy Immunol 2017
Nov 27, 2017Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland
Nov 27, 2017Clin Rev Allergy Immunol 2017
Terziroli Beretta-Piccoli Benedetta, Carbone Marco, Invernizzi Pietro, Baserga Adriana, Oneta Carl, Filipowicz Sinnreich Magdalena, Giostra Emiliano, Bihl Florian, Kalid-de Bakker Carolina, Stickel Felix, Helbling Beat, Hessler Roxane, Semela David, Cerny Andreas, Stirnimann Guido, Mertens Joachim
Trends in hepatitis C-related mortality in Switzerland
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela D, Terziroli B, Bruggmann P, Moradpour D, Dufour J, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort. Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat 2017; 25:152-160.
Nov 20, 2017Trends in hepatitis C-related mortality in Switzerland
Nov 20, 2017J Viral Hepat 2017; 25:152-160
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela David, Terziroli B, Bruggmann P, Moradpour D, Dufour J-F, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
Bruggmann P, Stoeckle M, Semela D, Schmid P, Razavi H, Rauch A, Mullhaupt B, Lavanchy D, Kouyos R, Fehr J, Deltenre P, Blach S, Negro F. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Med Wkly 2017; 147:w14543.
Nov 9, 2017Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
Nov 9, 2017Swiss Med Wkly 2017; 147:w14543
Bruggmann Philip, Stoeckle Marcel, Semela David, Schmid Patrick, Razavi Homie, Rauch Andri, Mullhaupt Beat, Lavanchy Daniel, Kouyos Roger, Fehr Jan, Deltenre Pierre, Blach Sarah, Negro Franco
Use of a Novel Ultrasonic Imaging Technique in the Diagnosis of Focal Nodular Hyperplasia . case series
Sawatzki M, Semela D, Neuweiler J, Brand S (2017). Use of a Novel Ultrasonic Imaging Technique in the Diagnosis of Focal Nodular Hyperplasia . case series.
Sep 15, 2017Use of a Novel Ultrasonic Imaging Technique in the Diagnosis of Focal Nodular Hyperplasia . case series
Sep 15, 2017Jahreskongress SGG
Sawatzki Mikael, Semela David, Neuweiler Jörg, Brand Stephan
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland
Fraga M, Sahli R, Greub G, Telenti A, Aubert V, Terziroli Beretta-Piccoli B, Stickel F, Semela D, Ripellino P, Mullhaupt B, Brunner F, Bihl F, Moulin H, Doerig C, Moradpour D. Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland. Liver Int 2017
Aug 23, 2017Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland
Aug 23, 2017Liver Int 2017
Fraga Montserrat, Sahli Roland, Greub Gilbert, Telenti Amalio, Aubert Vincent, Terziroli Beretta-Piccoli Benedetta, Stickel Felix, Semela David, Ripellino Paolo, Mullhaupt Beat, Brunner Felix, Bihl Florian, Moulin Hervé, Doerig Christopher, Moradpour Darius
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
Kolly P, Waidmann O, Vermehren J, Moreno C, Vögeli I, Berg T, Semela D, Zeuzem S, Dufour J. Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study. J Hepatol 2017; 67:876-878.
Jul 19, 2017Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
Jul 19, 2017J Hepatol 2017; 67:876-878
Kolly Philippe, Waidmann Oliver, Vermehren Johannes, Moreno Christophe, Vögeli Isabelle, Berg Thomas, Semela David, Zeuzem Stefan, Dufour Jean-François
Visualization of hepatitis E virus RNA and proteins in the human liver
Lenggenhager D, Moradpour D, Sempoux C, Mullhaupt B, Rubbia-Brandt L, Terracciano L, Sahli R, Fraga M, Aepli P, Hürlimann S, Neuweiler J, Semela D, Kreutzer S, Honcharova-Biletska H, Bawohl M, Malehmir M, Gouttenoire J, Weber A. Visualization of hepatitis E virus RNA and proteins in the human liver. J Hepatol 2017; 67:471-479.
Apr 13, 2017Visualization of hepatitis E virus RNA and proteins in the human liver
Apr 13, 2017J Hepatol 2017; 67:471-479
Lenggenhager Daniela, Moradpour Darius, Sempoux Christine, Mullhaupt Beat, Rubbia-Brandt Laura, Terracciano Luigi, Sahli Roland, Fraga Montserrat, Aepli Patrick, Hürlimann Sandra, Neuweiler Jörg, Semela David, Kreutzer Susanne, Honcharova-Biletska Hanna, Bawohl Marion, Malehmir Mohsen, Gouttenoire Jérôme, Weber Achim
A systematic review and meta-analysis of HCV clearance
Gauthiez E, Moradpour D, Mullhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud P, Malinverni R, Heim M, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Swiss Hepatitis C Cohort Study. A systematic review and meta-analysis of HCV clearance. Liver Int 2017; 37:1431-1445.
Mar 30, 2017A systematic review and meta-analysis of HCV clearance
Mar 30, 2017Liver Int 2017; 37:1431-1445
Gauthiez Emeline, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Semela David, Semmo Nasser, Villard Jean, Bibert Stéphanie, Bochud Pierre-Yves, Malinverni Raffaele, Heim Markus H, Habfast-Robertson Ines, Rüeger Sina, Kutalik Zoltán, Aubert Vincent, Berg Thomas, Cerny Andreas, Gorgievski Meri, George Jacob, Swiss Hepatitis C Cohort Study
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
De Gottardi A, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek F, Valla D, Garcia-Pagan J, Navascuès C, Mullhaupt B, Puente A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver Int 2016
Oct 25, 2016Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
Oct 25, 2016Liver Int 2016
De Gottardi Andrea, Nery Filipe, Deltenre Pierre, Turon Fanny, Engelmann Cornelius, Arya Rupen, Caca Karel, Peck-Radosavljevic Markus, Leebeek Frank W G, Valla Dominique, Garcia-Pagan Juan Carlos, Navascuès Carmen, Mullhaupt Beat, Puente Angela, Trebicka Jonel, Klinger Christoph, Plessier Aurélie, Seijo Susana, Terziroli Benedetta, Magenta Lorenzo, Semela David, Buscarini Elisabetta, Langlet Philippe, Görtzen Jan
DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Bachofner J, Mullhaupt B, Terziroli Beretta-Piccoli B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Bergamin I, Kröger A, Valli P, Mertens J. DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI. Liver Int 2016
Sep 28, 2016DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Sep 28, 2016Liver Int 2016
Bachofner Jacqueline A, Mullhaupt Beat, Terziroli Beretta-Piccoli Benedetta, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique, Baserga Adriana, Künzler-Heule Patrizia, Bergamin Irina, Kröger Arne, Valli Piero V, Mertens Joachim C
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation
Bernsmeier C, Heim M, Marra F, Tornillo L, Semela D, Muscogiuri G, Krol I, Makowska Z, Provenzano A, Dill M, Duong F. Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation. Lab Invest 2016; 96:972-80.
Jul 18, 2016Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation
Jul 18, 2016Lab Invest 2016; 96:972-80
Bernsmeier Christine, Heim Markus H, Marra Fabio, Tornillo Luigi, Semela David, Muscogiuri Giovanna, Krol Ilona, Makowska Zuzanna, Provenzano Angela, Dill Michael T, Duong Francois H T
Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study
Künzler-Heule P, Beckmann S, Mahrer-Imhof R, Semela D, Händler-Schuster D. Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study. J Clin Nurs 2016; 25:2559-68.
May 11, 2016Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study
May 11, 2016J Clin Nurs 2016; 25:2559-68
Künzler-Heule Patrizia, Beckmann Sonja, Mahrer-Imhof Romy, Semela David, Händler-Schuster Daniela
Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland
Bruggmann P, Negro F, Bihl F, Blach S, Lavanchy D, Mullhaupt B, Razavi H, Semela D. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland. Swiss Med Wkly 2015; 145:w14221.
Dec 4, 2015Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland
Dec 4, 2015Swiss Med Wkly 2015; 145:w14221
Bruggmann Philip, Negro Francesco, Bihl Florian, Blach Sarah, Lavanchy Daniel, Mullhaupt Beat, Razavi Homie, Semela David
Systemic disease associated with noncirrhotic portal hypertension
Semela D. Systemic disease associated with noncirrhotic portal hypertension. Clin Liver Dis (Hoboken) 2015; 6:103-106.
Oct 28, 2015Systemic disease associated with noncirrhotic portal hypertension
Oct 28, 2015Clin Liver Dis (Hoboken) 2015; 6:103-106
Semela David
A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance
Wang H, Pichulik T, Mullhaupt B, Semela D, Dufour J, Bochud P, Bowie A, Kalinke U, Berg T, Weber A, Wiese M, Löffler M, El Maadidi S, Fischer J, Grabski E, Dickhöfer S, Klimosch S, Flannery S, Filomena A, Wolz O, Schneiderhan-Marra N, East-German and Swiss Hepatitis C Virus Study Groups. A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance. Hepatology 2015; 62:1375-87.
Sep 28, 2015A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance
Sep 28, 2015Hepatology 2015; 62:1375-87
Wang Hui, Pichulik Tica, Mullhaupt Beat, Semela David, Dufour Jean-François, Bochud Pierre-Yves, Bowie Andrew G, Kalinke Ulrich, Berg Thomas, Weber Alexander N R, Wiese Manfred, Löffler Markus W, El Maadidi Souhayla, Fischer Janett, Grabski Elena, Dickhöfer Sabine, Klimosch Sascha, Flannery Sinead M, Filomena Angela, Wolz Olaf-Oliver, Schneiderhan-Marra Nicole, East-German and Swiss Hepatitis C Virus Study Groups